Abstract: A dispersion may include 1 to 50% by weight of lithium metal phosphate of a general formula Li1+aM2?bNc(PO4)3+d, wherein M is Ti, Zr or Hf; N is a metal other than Li and M; 0?a?0.6, 0?b?0.6, 0?c?0.6, 0?d?0.8; and 50 to 99% by weight of trialkyl phosphate. A coating composition may include such a dispersion and such dispersions can be used in lithium ion batteries.

Abstract: The present invention relates to a method of extracting an alkanoic acid and/or ester thereof from an aqueous medium, the method comprising: (a) contacting the alkanoic acid and/or ester thereof in the aqueous medium with at least one extracting medium for a time sufficient to extract the alkanoic acid and/or ester thereof from the aqueous medium into the extracting medium, (b) separating the extracting medium with the extracted alkanoic acid and/or ester thereof from the aqueous medium wherein the extracting medium comprises: a mixture of at least one alkyl-phosphine oxide, preferably Trioctylphosphine oxide (TOPO), and at least one alkane wherein the alkane comprises at least 12 carbon atoms.

Abstract: A synbiotic preparation contains at least one probiotic strain and at least one amino acid or derivative displaying an effect in glucose metabolism management, such as diabetes prevention or prediabetes treatment. The preparation modulates satiety hormones, such as CCK, GLP-1, and PYY. Methods are developed to treat obesity, adiposity, type 2 diabetes, and metabolic syndrome with the preparation. A preparation also decreases fasting glucose levels in a subject.

Abstract: A composition has at least one ceramide and at least one mono-rhamnolipid. The composition may have a clear appearance. A process may involve producing a cosmetic or pharmaceutical formulation having at least one ceramide, by providing the aforementioned composition and adding a cosmetic or pharmaceutical acceptable carrier. A mono-rhamnolipid may be used for solubilizing and/or physical stabilization of a ceramide-containing composition.

Abstract: A process produces aliphatic monocarboxylic acids and ?,?-dicarboxylic acids or ?,?-dicarboxylic monoesters by electrochemical oxidation of unsubstituted or at least monosubstituted, monounsaturated or polyunsaturated fatty acids or fatty acid esters in the presence of an inorganic or organic nitrate salt in an electrolysis cell in a reaction medium in the presence of oxygen.

Abstract: An improved process can be used for the acid hydrolysis of polylaurolactam with sulfuric acid. An especially suitable starting material is polylaurolactam which is intended for recycling and which is characterized by a low laurolactam content.

Abstract: The present invention is directed to bioresorbable polymers to be used as bone and tissue adhesives. The present invention is also directed to the synthesis of bioresorbable polymeric molecules bearing adhesive moieties and the use of such compounds in methods to glue and stabilize fractured bones and damaged tissues. The present invention is also directed to the use of such compounds as adhesive sealants for applications in wound care. The present invention is also directed to the use of such compounds as biodegradable ink for applications in tissue engineering and 3D printing. The present invention also relates to the use of such compounds as drug delivery platforms.

Abstract: A novel urea (meth)acrylate can be prepared by a process involving reacting a urea containing alcohol or amine with a (meth)acrylate, (meth)acryloyl chloride, (meth)acrylic acid, or (meth)acrylic anhydride. A binder composition includes at least one repeating unit derived from the urea (meth)acrylate. The binder composition can be used in adhesive and coating applications.

Abstract: A process produces unsubstituted or at least singly substituted cycloalkanones by electrochemical oxidation of unsubstituted or at least singly substituted, saturated cycloaliphatic hydrocarbons in the presence of an inorganic or organic nitrate salt in an electrolysis cell in a reaction medium in the presence of oxygen.

Abstract: A process produces unsubstituted or at least monosubstituted ?,?-dicarboxylic acids and ketocarboxylic acids by electrochemical oxidation of unsubstituted or at least monosubstituted, monounsaturated or polyunsaturated cycloalkenes by electrochemical oxidation in the presence of an inorganic or organic nitrate salt in an electrolysis cell in a reaction medium in the presence of oxygen.

Abstract: The invention discloses preparations for use in enhancing formation of short-chain fatty acids (SCFAs) in a subject for treating or preventing a disease or disorder comprising at least one omega-3 fatty acid salt having an organic counter ion selected from lysine, arginine, ornithine, choline and mixtures of the same, wherein the omega-3 fatty acid is selected from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and a colon-specific delivery system.

Abstract: PMMA-based rigid foams can be used as the core material of sandwich components in rotor blades of wind power plants and in boatbuilding.

Abstract: Rhamnolipids and/or sophorolipids can be used in coating compositions for improvement of the speed of wetting of pulverulent formulation constituents in such compositions, which leads to a reduction in dust nuisance during incorporation thereof and to the increase in occupational safety in the production of coating compositions. Rhamnolipids and/or sophorolipids can also be used in coating compositions for obtaining improved homogeneous colour appearance of the dry paint film with regard to difference in hue, ascertained from the delta E and visual assessment.

Abstract: A one-pot synthesis of polymerizable and acyclic urea (meth)acrylates, preferably mono(meth)acrylates, can be performed via in-situ synthesis of urea alcohols or amines followed by direct reaction with a (meth)acrylate reactive diluent. The urea alcohol/amine is obtained from isocyanates and alcohols, amines, or hydroxyamines. Subsequently, the reaction with the (meth)acrylate reactive diluent takes place and the urea (meth)acrylate is directly obtained either in solution with the reactive diluent, or as a pure material after removal of the reactive diluent.

Abstract: Crosslinkable compositions are developed based on an elastomer-containing powder or pelletized material, for instance composed of recycled material such as used tyres, including specific additives, and to elastomer compounds and articles obtainable therefrom, and to methods for the production thereof. The crosslinkable composition includes (a) a powder or pelletized material including at least one elastomer, (b) at least one poly-C5-C15-alkenamer, (c) at least one liquid poly butadiene, and (d) at least one crosslinking agent.

Abstract: The present invention relates to ammonium salts of formula (I) where R=—H, —CH3, —CH2CH3; n=1, 2, 3, 4, 5; m=2, 3; R?, R?, R??=—CH3, —CH2CH3; RIV=—H, —CH3, —CH2CH3 and X=monovalent counterion, to a process for their production and to the use thereof.

Abstract: A synbiotic preparation may include at least one probiotic strain and at least one amino acid or derivative thereof selected from glutamine, glutamic acid or salts thereof, conjugated glutamine, or oligopeptides of 2-10 amino acid units in length, wherein the amino acid units may be natural amino acids, and at least one amino acid unit being a glutamine or glutamic acid unit.

Abstract: A catalyst may include a support and from 5 to 20 wt.-% of a promoter, based on the total weight of the catalyst, wherein the support may include titanium dioxide, zirconium dioxide, and/or a mixture thereof, and the promoter may be an alkali metal oxide. Processes for preparing such catalysts may include impregnating a support of titanium dioxide and/or zirconium dioxide with an aqueous solution including a preferably soluble alkali compound and calcining. Alkyl mercaptans may be prepared in the presence of such catalysts or catalysts obtained by such processes.

Abstract: The invention provides fumed silica granules having a BET surface area of 20 m2/g to 500 m2/g; a number average particle size d50 of 350 ?m to 2000 ?m; a span (d90?d10)/d50 of particle size distribution of 0.8-3.0; a bulk density of more than 0.35 g/mL; a pore volume for pores >4 nm of not more than 1.5 cm3/g, process for its preparation and use thereof as a catalyst carrier, a carrier for liquid substances, in cosmetic applications, for thermal insulation, as pharmaceutical excipient, in producing thermally treated silica granules, as an abrasive, as a component of a silicone rubber.

Abstract: A method manufactures an RNA- or DNA-containing virus particle in cell culture, a supplement for a culture medium and a culture medium for producing of RNA or DNA-containing virus particles having one or more dipeptides or derivatives thereof, wherein one dipeptide is glycyl-glutamine (Gly-Gln), by providing a cell capable of producing the virus particle, contacting the cell with a culture medium with at least one dipeptide or derivatives thereof and obtaining the virus particle from the culture medium or from the cell.